Back
ALX Oncology Holdings Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
36
ALXO
ALX Oncology Holdings
Last Price:
1.53
Seasonality Move:
30.31%
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
66.75
Seasonality Move:
13.3%
Sell
36
ALX Oncology Holdings (ALXO)
is a Sell
Is ALX Oncology Holdings a Buy, Sell or Hold?
- The current ALX Oncology Holdings [ALXO] share price is $1.53. The Score for ALXO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ALXO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.14. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALXO Stock Price Chart
What is ALX Oncology Holdings's stock price today?
-
The ALX Oncology Holdings share price today is $1.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALXO is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
ALXO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 43.67 | Sell |
| Chaikin Money Flow: | 281250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.44 - 1.64) | Sell |
| Bollinger Bands (100): | (1.29 - 5.61) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 30.39 | Sell |
| Chaikin Money Flow: | -992643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.33 - 70.61) | Sell |
| Bollinger Bands (100): | (71.38 - 88.36) | Sell |
ALXO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.46 | Buy |
| 20-day SMA: | 1.5 | Buy |
| 50-day SMA: | 1.82 | Sell |
| 200-day SMA: | 8.58 | Sell |
| 8-day EMA: | 1.49 | Buy |
| 20-day EMA: | 1.55 | Sell |
| 50-day EMA: | 2.15 | Sell |
| 200-day EMA: | 6.23 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.17 | Sell |
| 20-day SMA: | 68.97 | Sell |
| 50-day SMA: | 74.08 | Sell |
| 200-day SMA: | 82.58 | Sell |
| 8-day EMA: | 67.03 | Sell |
| 20-day EMA: | 68.71 | Sell |
| 50-day EMA: | 72.98 | Sell |
| 200-day EMA: | 81.27 | Sell |
ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.24 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
ALX Oncology Holdings Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||